36 related articles for article (PubMed ID: 34628209)
21. Tissue Adequacy and Safety of Percutaneous Transthoracic Needle Biopsy for Molecular Analysis in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Nam BD; Yoon SH; Hong H; Hwang JH; Goo JM; Park S
Korean J Radiol; 2021 Dec; 22(12):2082-2093. PubMed ID: 34564960
[TBL] [Abstract][Full Text] [Related]
22. Should We Perform Repeated Re-biopsy for the Detection of T790M Mutation?
Kim S; Kim SH; Kim J; Kim MH; Lee MK; Eom JS
Cancer Res Treat; 2023 Oct; 55(4):1190-1197. PubMed ID: 37080607
[TBL] [Abstract][Full Text] [Related]
23. Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.
Kuiper JL; Heideman DA; Thunnissen E; Paul MA; van Wijk AW; Postmus PE; Smit EF
Lung Cancer; 2014 Jul; 85(1):19-24. PubMed ID: 24768581
[TBL] [Abstract][Full Text] [Related]
24. Biopsy on progression in patients with
Chu Q; Agha A; Devost N; Walton RN; Ghosh S; Ho C
Curr Oncol; 2020 Feb; 27(1):27-33. PubMed ID: 32218657
[TBL] [Abstract][Full Text] [Related]
25. Mind-mapping for lung cancer: towards a personalized therapeutics approach.
Mollberg N; Surati M; Demchuk C; Fathi R; Salama AK; Husain AN; Hensing T; Salgia R
Adv Ther; 2011 Mar; 28(3):173-94. PubMed ID: 21337123
[TBL] [Abstract][Full Text] [Related]
26. Adequacy of samples obtained via percutaneous core-needle rebiopsy for EGFR T790M molecular analysis in patients with non-small cell lung cancer following acquired resistance to first-line therapy: A systematic review and meta-analysis.
Poudel B; Desman J; Aihara G; Weidman DI; Tsang A; Kovrizhkin K; Pereira T; Arun S; Pradeep T; Matin S; Liddell RP
Cancer Treat Res Commun; 2021; 29():100470. PubMed ID: 34628209
[TBL] [Abstract][Full Text] [Related]
27. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.
Zhang Z; Wang T; Zhang J; Cai X; Pan C; Long Y; Chen J; Zhou C; Yin X
PLoS One; 2014; 9(8):e106053. PubMed ID: 25162713
[TBL] [Abstract][Full Text] [Related]
29. Lung transplantation for lung cancer: A systematic review of the literature.
Elsolh B; Bayat Z; Lyu D; Lin J; Wakeam E
J Heart Lung Transplant; 2023 Oct; 42(10):1425-1436. PubMed ID: 37253398
[TBL] [Abstract][Full Text] [Related]
30. Optimizing molecular testing of lung cancer needle biopsy specimens: potential solutions from an interdisciplinary qualitative study.
Fintelmann FJ; Martin NA; Tahir I; Quinn EM; Allen TC; Joseph L; Nikolic B; Lee C
Respir Res; 2023 Jan; 24(1):17. PubMed ID: 36650544
[TBL] [Abstract][Full Text] [Related]
31. Multiple mutations in the
Castañeda-González JP; Chaves JJ; Parra-Medina R
Transl Lung Cancer Res; 2022 Oct; 11(10):2148-2163. PubMed ID: 36386461
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
